The platform will provide Vanderbilt researchers with diverse datasets and aims to advance insights for drug discovery and patient care, according to a July 25 press release from Vanderbilt.
“Nference’s advanced capability to utilize information gathered from electronic health records, imaging data, and digital pathology data, when combined with our historic and deep experience and leadership in biomedical informatics and health information technology, allows us to advance the understanding of devastating diseases while accelerating biomedical research,” said Jeff Balser, MD, PhD, president and CEO of Vanderbilt University Medical Center.
Nference’s AI-enabled clinical analytics platform, dubbed nSights, provides datasets for therapeutic areas such as cardiology, immunology and rare diseases.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
